{"id":1371239,"title":"DSEN Abstract: No evidence identified interventions that decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin 5-hydroxytryptamine 3 receptor (5-HT3) antagonists - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-21","captureTimestamp":"2026-03-21T16:14:59.247000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52121.html","snippet":"DSEN Abstract No evidence identified interventions that decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin 5-hydroxytryptamine 3 receptor (5-HT3) antagonists This research was funded by the Drug Safety and Effectiveness Network (DSEN)…","rawSnapshotUrl":"/api/snapshots/raw/1371239","browseUrl":"https://replay.healtharchive.ca/job-8/20260321161459/https://cihr-irsc.gc.ca/e/52121.html#ha_snapshot=1371239","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}